Concepedia

DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity

Chen Yang, Joseph Ciccolini, Aurore Blesius, Laëtitia Dahan, D. Bagarry-Liégey, Caroline Brunet, A. Varoquaux, Nicolas Frances, Hafedh Marouani, Antoine Giovanni,

Cancer Chemotherapy and Pharmacology · 2010 · 77 citations · 23 references

DOI

Concepts

References

23

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

, , +15

Global Cancer Statistics, 2002

Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text

, , +16

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

, , +9

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

, , +8

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Charlotte Jacobs, Gary H. Lyman, E Vélez-García et al. · Journal of Clinical Oncology · 1992 · 633 citations

, , +11